Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dallavalle

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tumori|January 1, 1997
Response evaluation as the key-point in results interpretationR Labianca, G Pancera, G Dallavalle, et al.
Tumori|February 29, 1992
High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratioR Labianca, G Pancera, L Tedeschi, et al.
Cancer|November 15, 1994
Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastineL Brambilla, R Labianca, V Boneschi, et al.
Annali Italiani Di Chirurgia|November 1, 1996
[Locoregional chemotherapy of liver metastasis from colorectal carcinoma]G Zamparelli, G Pancera, M A Pessi, et al.
Journal of Clinical Gastroenterology|March 1, 1994
Stages I and II non-Hodgkin's lymphoma of the gastrointestinal tract. Retrospective analysis of 79 patients and review of the literatureL Tedeschi, A Romanelli, G Dallavalle, et al.
Oncology|March 1, 1993
A cisplatinum-cyclophosphamide regimen in advanced ovarian cancer: reporting 5-year resultsM C Locatelli, A D'Antona, R Carcione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric studyE Díaz-Rubio, J Sastre, A Zaniboni, et al.
Cancer Detection and Prevention|April 2, 1999
Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term resultsM C Locatelli, G Facendola, G Pizzocaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract CancerR Labianca, S Cascinu, L Frontini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tumori|January 1, 1997
Response evaluation as the key-point in results interpretationR Labianca, G Pancera, G Dallavalle, et al.
Tumori|February 29, 1992
High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratioR Labianca, G Pancera, L Tedeschi, et al.
Cancer|November 15, 1994
Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastineL Brambilla, R Labianca, V Boneschi, et al.
Annali Italiani Di Chirurgia|November 1, 1996
[Locoregional chemotherapy of liver metastasis from colorectal carcinoma]G Zamparelli, G Pancera, M A Pessi, et al.
Journal of Clinical Gastroenterology|March 1, 1994
Stages I and II non-Hodgkin's lymphoma of the gastrointestinal tract. Retrospective analysis of 79 patients and review of the literatureL Tedeschi, A Romanelli, G Dallavalle, et al.
Oncology|March 1, 1993
A cisplatinum-cyclophosphamide regimen in advanced ovarian cancer: reporting 5-year resultsM C Locatelli, A D'Antona, R Carcione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric studyE Díaz-Rubio, J Sastre, A Zaniboni, et al.
Cancer Detection and Prevention|April 2, 1999
Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term resultsM C Locatelli, G Facendola, G Pizzocaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract CancerR Labianca, S Cascinu, L Frontini, et al.
Pageof 1